Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial

被引：0
|
作者：
Hasan Mirzazadeh [1 ]
Younes Ghaeminia [2 ]
Amin Mohamad Niaei [3 ]
Mohammadsadegh Kamran [4 ]
Leila Razeghian Jahromi [1 ]
Reza Moshfeghinia [1 ]
机构：
[1] Shiraz University of Medical Sciences,Research Center for Psychiatry and Behavior Science
[2] Shiraz University of Medical Sciences,School of Medicine
[3] Lorestan University of Medical Sciences,Student Research Committee
[4] Fasa University of Medical Sciences,Student Research Committee
[5] Shiraz University of Medical Science,Student’s research committee
[6] Shiraz University of Medical Sciences,Substance Abuse Research Center
来源：
BMC Psychiatry | / 25卷 / 1期
关键词：
Memantine; Escitalopram; Obsessive-Compulsive Disorder (OCD); Executive function; Augmentation therapy;
D O I：
10.1186/s12888-025-06856-7
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
  • [32] A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder
    Strawn, Jeffrey R.
    Moldauer, Leslie
    Hahn, Rebekah D.
    Wise, Alexandria
    Bertzos, Kristina
    Eisenberg, Beth
    Greenberg, Edward
    Liu, Chengcheng
    Gopalkrishnan, Mallika
    McVoy, Molly
    Knutson, James A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (03) : 91 - 100
  • [33] Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
    Veerman, S. R. T.
    Schulte, P. F. J.
    Smith, J. D.
    de Haan, L.
    PSYCHOLOGICAL MEDICINE, 2016, 46 (09) : 1909 - 1921
  • [34] Pharmacotherapy Relapse Prevention with Escitalopram in Body Dysmorphic Disorder: A Double-Blind Placebo-Controlled Trial
    Phillips, Katharine
    Kesheviah, Aparna
    Dougherty, Darin
    Stout, Robert
    Menard, William
    Wilhelm, Sabine
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S119 - S119
  • [35] Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study
    Noruzzadeh, Rezvan
    Modabbernia, Amirhossein
    Aghamollaii, Vajiheh
    Ghaffarpour, Majid
    Harirchian, Mohammad Hossein
    Salahi, Sarvenaz
    Nikbakht, Nikta
    Noruzi, Nahid
    Tafakhori, Abbas
    HEADACHE, 2016, 56 (01): : 95 - 103
  • [36] Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial
    Anand, Amit
    Gunn, Abigail D.
    Barkay, Gavriel
    Karne, Harish S.
    Nurnberger, John I.
    Mathew, Sanjay J.
    Ghosh, Samiran
    BIPOLAR DISORDERS, 2012, 14 (01) : 64 - 70
  • [37] Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trials
    Goodman, WK
    Bose, A
    Wang, Q
    JOURNAL OF AFFECTIVE DISORDERS, 2005, 87 (2-3) : 161 - 167
  • [38] Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study
    Stein, Dan J.
    Andersen, Elisabeth Wreford
    Tonnoir, Brigitte
    Fineberg, Naomi
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 701 - 711
  • [39] Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease
    Choe, Young Min
    Kim, Ki Woong
    Jhoo, Jin Hyeong
    Ryu, Seung Ho
    Seo, Eun Hyun
    Sohn, Bo Kyung
    Byun, Min Soo
    Bak, Jae-Hwa
    Lee, Jong-Min
    Yun, Hyuk Jin
    Han, Myeong-il
    Woo, Jong Inn
    Lee, Dong Young
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 31 (07) : 731 - 739
  • [40] Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study With Pharmacogenomic and Pharmacokinetic Measures
    Strawn, Jeffrey
    Mills, Jeffrey
    Schroeder, Heidi
    Mossman, Sarah
    Varney, Sara
    Ramsey, Laura
    Poweleit, Ethan
    Desta, Zeruesenay
    Cecil, Kim
    DelBello, Melissa
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 88 - 89
12345